Riskpilot← Back to searchSign inGet full accessNH Medical AB
ABActiveOrg 5593746588Drakenbergsgatan 33 Lgh 1501General medical practice activities · NACE 8621Est. 20220 employees
Revenue 2025
SEK 1,4M
+822% vs 2024
EBITDA margin
83.4%
+1212% vs 2024
Equity ratio
67.3%
Financial strength
Net profit 2025
SEK 911K
+1393% vs 2024
| Revenue | SEK 1,4M | +822% |
| EBITDA | SEK 1,2M | +1212% |
| Net profit | SEK 911K | +1393% |
| Total assets | SEK 1,6M | +278% |
| Equity | SEK 1,1M | +185% |
| Employees | 0 | — |
Legal name
NH Medical AB
Org number
5593746588
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
6 april 2022
Share capital
SEK 25 000
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-03-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Företaget kommer främst verka genom konsultverksamhet med hyrläkaruppdrag inom både öppen- och slutenvård samt digitalt i sjukvården där behov finns. Det kommer även tillhandahållas tjänster som konsult inom utbildning så som medicinska föreläsningar. Företaget ska kunna bedriva verksamhet inom kosmetiska behandlingar och utföra kosmetiska ingrepp. Företaget ska äga, förvalta och handla med värdepapper.
Address
Drakenbergsgatan 33 Lgh 1501
Email
nils_hoff@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 695 | 157 | 1 448 |
| Staff expenses | — | — | — |
| EBITDA | 615 | 92 | 1 207 |
| Depreciation & amort. | −3 | −14 | −45 |
| EBIT | 612 | 78 | 1 162 |
| Net financials | — | — | −5 |
| Profit before tax | 612 | 78 | 1 157 |
| Tax | −126 | −17 | −246 |
| Net profit | 486 | 61 | 911 |
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 780 | 430 | 1 626 |
| Equity | 511 | 384 | 1 095 |
| Long-term debt | 0 | 0 | 0 |
| Short-term debt | 269 | 46 | 531 |
| Total debt | 269 | 46 | 531 |
EBITDA margin
83.4%
This company
15.8%
Market median
+428% vs market
20232025
Equity ratio
67.3%
This company
38.2%
Market median
+76% vs market
20232025
Return on equity
83.2%
This company
18.4%
Market median
+352% vs market
20232025
Net profit margin
62.9%
This company
8.1%
Market median
+677% vs market
20232025
Asset turnover
0.89×
This company
1.12×
Market median
+21% vs market
20232025
Debt / equity
0.48×
This company
0.62×
Market median
+23% vs market
20232025
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2024 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NH Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nils Gustav Ragnar Hoff | Board of Directors | 0 companies |
| Sanna Maria Bergström | Deputy Board Member | 0 companies |
| Elin Karin Alma Hoff | Deputy Board Member | 0 companies |